ClinicalTrials.gov
ClinicalTrials.gov Menu

Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00350818
Recruitment Status : Completed
First Posted : July 11, 2006
Last Update Posted : July 30, 2012
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2010
  Actual Study Completion Date : August 2010